Application 219556
- Type
- ANDA
- Sponsor
- EPIC PHARMA LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXCARBAZEPINE | OXCARBAZEPINE | TABLET;ORAL | 150MG | No | No |
| 002 | OXCARBAZEPINE | OXCARBAZEPINE | TABLET;ORAL | 300MG | No | No |
| 003 | OXCARBAZEPINE | OXCARBAZEPINE | TABLET;ORAL | 600MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219556-001 | OXCARBAZEPINE | OXCARBAZEPINE | 150MG | TABLET / ORAL | AB | 2026-03-02 | |
| A219556-002 | OXCARBAZEPINE | OXCARBAZEPINE | 300MG | TABLET / ORAL | AB | 2026-03-02 | |
| A219556-003 | OXCARBAZEPINE | OXCARBAZEPINE | 600MG | TABLET / ORAL | AB | 2026-03-02 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219556-001 | AB |
| A219556-002 | AB |
| A219556-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219556-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | AB | 2026-03-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219556-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | AB | 2026-03-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219556-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | AB | 2026-03-02 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A219556-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | AB | 2026-03-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219556-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | AB | 2026-03-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219556-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | AB | 2026-03-02 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219556-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | AB | 2026-03-02 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219556-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | AB | 2026-03-02 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219556-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | AB | 2026-03-02 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219556-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219556-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219556-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A219556-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219556-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219556-003 | AB | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219556-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219556-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219556-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OXCARBAZEPINE | OXCARBAZEPINE | Bryant Ranch Prepack | 38694974-3dc6-42b5-bdf9-b5354e35330b | 2024-10-25 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Direct_rx | 21b0cc84-b64a-75de-e063-6294a90a9dd0 | 2024-09-09 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Bryant Ranch Prepack | d8edaa2b-3bab-4030-a4e3-0c77f7655731 | 2024-07-16 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | XLCare Pharmaceuticals Inc. | 9f5d17e4-ca68-48e2-9e87-d3ab1c59aa93 | 2024-07-16 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Bryant Ranch Prepack | 78f196d4-110e-45b1-813a-725f52c1a4eb | 2024-04-04 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Bryant Ranch Prepack | d3c7a3b8-b9a2-4a5f-98b3-0ed02eca3433 | 2024-04-02 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Biocon Pharma Inc. | 62dfed1d-4c5b-446d-97b3-bad9c33959ff | 2024-03-20 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Bryant Ranch Prepack | 255f64ba-7667-48e6-8599-3b598bf6f4e9 | 2024-01-12 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Breckenridge Pharmaceutical, Inc. | 682a1210-b26e-426e-8ffe-d25d91bdd608 | 2024-01-09 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Precision Dose, Inc. | 636fc847-b3d2-4255-a959-d75499fdb198 | 2023-11-20 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Proficient Rx LP | 95867dcd-fd0e-4570-987b-d35939f7d7d1 | 2022-11-01 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Kanchan Healthcare Inc | 7be73d22-f87b-4459-a91c-37c1e34db230 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.